Corient Private Wealth
ONC

Corient Private Wealth’s BeOne Medicines Ltd ONC Stock Holding History

Corient Private Wealth’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$295K Sell
1,005
-1,128
-53% -$365K ﹤0.01% 2325
2025
Q4 		$648K Buy
2,133
+1,288
+152% +$422K ﹤0.01% 2157
2025
Q3 		$288K Buy
+845
New +$257K ﹤0.01% 2147

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Corient Private Wealth's ONC Position: Q1 2026 in Review

Corient Private Wealth reduced its BeOne Medicines Ltd (ONC) stake by 53% in Q1 2026, selling an estimated $365K and leaving 1,005 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #2325.

Corient Private Wealth first reported a position in ONC in Q3 2025 and has held it in 3 quarters since. The position peaked at $648K in Q4 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Corient Private Wealth held 1,005 shares of BeOne Medicines Ltd worth $295K as of Q1 2026.
  • Corient Private Wealth sold 1,128 BeOne Medicines Ltd shares in Q1 2026, an estimated $365K.
  • BeOne Medicines Ltd made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2325 holding.
  • Corient Private Wealth first reported a position in BeOne Medicines Ltd in Q3 2025 and has held it in 3 quarters since.
  • Corient Private Wealth's BeOne Medicines Ltd position peaked at $648K in Q4 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.